Anew Labs has closed a USD 290 million financing round, with HSG and other investors participating in the investment.

36Kr has learned that AI pharmaceutical firm Anew Labs has recently completed its first round of independent financing, with a total financing amount of 290 million U.S. dollars. The investors in this round cover investment institutions including HSG, IDG Capital, GL Ventures, 5Y Capital and Gaorong Capital, while a number of domestic pharmaceutical industry groups also participated as strategic investors. It is understood that in June this year, ByteDance spun off its AI pharmaceutical business line, positioning Anew Labs as the independent brand entity of this business segment.